
Alan Lyons received a Sc.B. in chemistry from Brown
University and Ph.D. in polymer chemistry from NYU-Tandon School of Engineering. He was a Distinguished Member of Technical
Staff with the research division of Bell Laboratories and a founding member of
Bell Labs Ireland. He then joined the City University of New York (CUNY)
Graduate Center and College of Staten Island, as a Professor in the Department
of Chemistry. His work at CUNY has focused
on developing multi-functional surfaces with novel wetting, optical and
catalytic properties. He has authored
over 60 publications and is the inventor of 40 issued patents, five of which
have resulted from his work at CUNY.
Based on this work, he has co-founded two companies: SingletO2 Therapeutics LLC which is
developing bandages that kill bacteria and accelerate wound healing and ARL
Designs LLC, which is developing anti-soiling coatings for photovoltaic solar
glass.